In vitro cytotoxicity andin vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels
- 5 May 1999
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
Abstract
The in vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) [P(PF-co-EG)] hydrogels were assessed in order to investigate the influence of poly(ethylene glycol) molecular weight and copolymer composition. These materials have application as injectable cardiovascular implants; cytotoxicity due to leachable products, as well as inflammation caused by the biomaterial itself, may ultimately affect the biocompatibility of the implant. We utilized a 7-day in vitro cytotoxicity assay to quantify cell density and cellular proliferation in the presence of copolymer films. The copolymer films exhibited slight to moderate cytotoxicity toward cultured endothelial cells, showing 20–86% viability relative to controls. Cell viability increased with an increasing weight percent of PEG or, to a lesser extent, the molecular weight of PEG. In vivo biocompatibility was assessed using a cage implantation model over a 21-day time period. This system was used to characterize the local cellular and humoral inflammatory response in the surrounding exudate, as well as the size and density of macrophages adherent to the material itself. All copolymer formulations exhibited excellent biocompatibility relative to controls with no significant differences in total leukocyte count among the different formulations. The in vivo inflammatory reaction displayed normal wound healing over 21 days as shown by a progressive decrease in both leukocyte concentration and enzymatic activity. The surface coverage of the copolymer films remained relatively constant from 7 to 21 days. There were no cells larger than 0.003 mm2, which was previously shown to be the threshold value for foreign-body giant cells. These data suggest that P(PF-co-EG) hydrogels have potential for use as injectable biomaterials.© 1999 John Wiley & Sons, Inc. J Biomed Mater Res, 46, 22–32, 1999.Keywords
This publication has 21 references indexed in Scilit:
- Synthesis and Characterization of a Block Copolymer Consisting of Poly(propylene fumarate) and Poly(ethylene glycol)Macromolecules, 1997
- Restenosis-an open fileClinical Cardiology, 1996
- A new method for continual quantitation of viable cells on endothelialized polyurethanesJournal of Biomaterials Science, Polymer Edition, 1996
- Nitric Oxide Regulation of IL-8 Expression in Human Endothelial CellsBiochemical and Biophysical Research Communications, 1995
- Pharmacologic prevention of restenosis after coronary angioplastyCoronary Artery Disease, 1993
- Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal AngioplastyNew England Journal of Medicine, 1987
- Direct mass spectrometry of polymers. XIV. Thermal fragmentation processes in poly-schiff basesJournal of Polymer Science Part A: Polymer Chemistry, 1986
- In vivo biocompatibility studies. VII. Inflammatory response to polyethylene and to a cytotoxic polyvinylchlorideJournal of Biomedical Materials Research, 1986
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984
- Structure–property relationships of a new series of segmented polyether–polyester copolymersJournal of Applied Polymer Science, 1981